ApoER2 Protein

📖 Wiki Page

protein937 wordssynced 2026-04-02

ApoER2 (LRP8) Protein

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">ApoER2 Protein</th>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>LRP8</td>
</tr>
<tr>
<td class="label">Protein Name</td>
<td>Apolipoprotein E Receptor 2 (ApoER2)</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>~110 kDa (full-length), 85 kDa (truncated)</td>
</tr>
<tr>
<td class="label">Structure</td>
<td>963 amino acids</td>
</tr>
<tr>
<td class="label">Aliases</td>
<td>LDLRR, LR8, APOER2</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>Q9UBJ2</td>
</tr>
<tr>
<td class="label">Tissue Expression</td>
<td>Brain (neurons), testis, platelets</td>
</tr>
<tr>
<td class="label">Partner</td>
<td>Interaction Type</td>
</tr>
<tr>
<td class="label">Reelin</td>
<td>Ligand binding</td>
</tr>
<tr>
<td class="label">VLDLR</td>
<td>Co-receptor</td>
</tr>
<tr>
<td class="label">Dab1</td>
<td>Adaptor protein</td>
</tr>
<tr>
<td class="label">APOE</td>
<td>Ligand binding</td>
</tr>
<tr>
<td class="label">[NMDA Receptor](/entities/nmda-receptor)</td>
<td>Physical association</td>
</tr>
<tr>
<td class="label">PSD-95</td>
<td>Scaffold interaction</td>
</tr>
<tr>
<td class="label">Approach</td>
<td>Status</td>
</tr>
<tr>
<td class="label">Reelin mimetics</td>
<td>Preclinical</td>
</tr>
<tr>
<td class="label">Dab1 stabilizers</td>
<td>Discovery</td>
</tr>
<tr>

...

ApoER2 (LRP8) Protein

Introduction

Apoer2 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

Overview

ApoER2 ([Apolipoprotein E](/proteins/apoe) Receptor 2), also known as LRP8, is a member of the Low-Density Lipoprotein Receptor family. It is primarily expressed in the brain and plays critical roles in synaptic function, neuronal development, and lipid metabolism. ApoER2 is a key receptor for both Reelin signaling and apolipoprotein E (APOE)-containing lipoproteins, making it a crucial nexus between lipid metabolism and neuronal function. The receptor is expressed predominantly in neurons throughout the brain, with highest levels in the hippocampus, cortex, and cerebellum. [@herz2006]

Protein Information

Structure

ApoER2 is a type I transmembrane glycoprotein with multiple functional domains:

Extracellular Domain

Ligand-Binding Repeats (8): Cys-rich repeats that bind Reelin and APOE
EGF-Like Repeats (3): Required for pH-dependent ligand release
Truncated Isoforms: Brain-expressed isoforms lack some repeats

Transmembrane Domain

Single alpha-helical transmembrane segment
Links extracellular and intracellular domains

Cytoplasmic Tail

NPXY Internalization Signals: Two NPXY motifs for endocytosis
Tyrosine Phosphorylation Sites: Critical for downstream signaling
Dileucine Motif: Additional sorting signal

Molecular Function

Reelin Signaling

ApoER2 is the primary Reelin receptor in neurons:

Reelin binds to ApoER2 (and VLDLR) with high affinity

Triggers Dab1 phosphorylation cascade

Inhibits glycogen synthase kinase-3β (GSK-3β)

Promotes microtubule stabilization

Enhances NMDA receptor function

Facilitates synaptic plasticity

Lipoprotein Receptor Function

Binds APOE-containing lipoproteins (primarily APOE4 isoform)
Mediates neuronal cholesterol uptake
Participates in brain lipid homeostasis
Regulates synaptic membrane composition

NMDA Receptor Modulation

Co-localizes with NMDA receptors at synapses
Enhances NMDA receptor phosphorylation
Potentiates NMDA-mediated calcium influx
Critical for [LTP](/mechanisms/long-term-potentiation) and memory formation

Expression Pattern

Brain Regional Distribution

[Hippocampus](/brain-regions/hippocampus): Highest expression in CA1 pyramidal neurons
Cerebral [Cortex](/brain-regions/cortex): Layer-specific expression patterns
Cerebellum: Purkinje cells and granule cells
Basal Ganglia: Moderate expression

Cell Type Specificity

[Neurons](/entities/neurons): Primary expression site
[Astrocytes](/entities/astrocytes): Low expression
[Microglia](/entities/microglia): Minimal expression
Endothelial Cells: Vascular expression

Developmental Regulation

Highest expression during embryonic development
Continues in adult brain
Regulated by neuronal activity

Disease Implications

Alzheimer's Disease

Genetic Variants: LRP8 polymorphisms modify AD risk
Aβ Metabolism: Affects [amyloid-beta](/proteins/amyloid-beta) clearance
APOE4 Interaction: APOE4-ApoER2 signaling is impaired
Synaptic Dysfunction: Contributes to memory deficits
Therapeutic Target: Reelin/ApoER2 signaling enhancement

Neurodevelopmental Disorders

Mutations cause autosomal recessive intellectual disability
Impaired Reelin signaling disrupts neuronal migration
Associated with cortical malformations
Comorbidities: epilepsy, motor deficits

Stroke and Cerebrovascular Disease

LRP8 polymorphisms modulate stroke risk
May affect cerebral vascular integrity
APOE4-ApoER2 interaction in vascular dementia
Potential for cerebrovascular therapeutics

Atherosclerosis

Expressed in vascular smooth muscle cells
May affect systemic lipid metabolism
Interaction with circulating lipoproteins

Molecular Mechanisms

Reelin Signaling Cascade

Reelin binds to ApoER2/VLDLR receptor complex

Src family kinases phosphorylate Dab1

Dab1 recruits PI3K and downstream effectors

Akt/PKB activation inhibits [GSK-3β](/entities/gsk3-beta)

Reduced [tau](/proteins/tau) phosphorylation

Enhanced synaptic plasticity

Interaction Network

Therapeutic Targeting

Current Strategies

Emerging Approaches

Gene therapy for LRP8 mutations
AAV-mediated Reelin delivery
Peptide agonists for ApoER2
Combination with APOE-targeting therapies

Animal Models

ApoER2 Knockout Mice: Mild neurological phenotype, enhanced [LTP](/mechanisms/long-term-potentiation) deficits with APOE4
Conditional Knockouts: Region-specific deletion studies
Transgenic Overexpression: Rescue of synaptic deficits

Research Directions

Defining isoform-specific functions
Developing brain-penetrant small molecules
Understanding APOE4-ApoER2 interaction in AD
Biomarker potential: soluble ApoER2 as marker

Background

The study of Apoer2 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

External Links

[LRP8 Protein - NCBI](https://www.ncbi.nlm.nih.gov/protein/NP_001018807)
[UniProt: Q9UBJ2](https://www.uniprot.org/uniprot/Q9UBJ2)
[LRP8 - GeneCards](https://www.genecards.org/cgi-bin/carddisp.pl?gene=LRP8)

References

[Trommsdorff et al., 1999, Reelin and ApoER2 in neuronal migration (1999)](https://pubmed.ncbi.nlm.nih.gov/10436159/)

[Unknown, Herz and Chen, 2006. LRP8 in neurodegeneration. Nat Rev Neurosci (2006)](https://pubmed.ncbi.nlm.nih.gov/16641937/)

[Lane-Donovan et al., 2014, Lipoprotein receptors in brain function (2014)](https://pubmed.ncbi.nlm.nih.gov/25148686/)

[Beffert et al., 2005, ApoER2 and Reelin in synaptic plasticity (2005)](https://pubmed.ncbi.nlm.nih.gov/15953421/)

[D'Arcangelo et al., 2009, Reelin signaling in neuropsychiatric disease (2009)](https://pubmed.ncbi.nlm.nih.gov/19680242/)

[Chen et al., 2010, LRP8 and Alzheimer's disease (2010)](https://pubmed.ncbi.nlm.nih.gov/20463221/)

[Hiesberger et al., 1999, Direct binding of Reelin to ApoER2 (1999)](https://pubmed.ncbi.nlm.nih.gov/10436158/)

[Bal et al., 2013, ApoER2 and NMDA receptor function (2013)](https://pubmed.ncbi.nlm.nih.gov/24162653/)

📖 View canonical wiki page →

ApoER2 Protein

ApoER2 (LRP8) Protein

ApoER2 (LRP8) Protein

Introduction

Overview

Protein Information

Structure

Extracellular Domain

Transmembrane Domain

Cytoplasmic Tail

Molecular Function

Reelin Signaling

Lipoprotein Receptor Function

NMDA Receptor Modulation

Expression Pattern

Brain Regional Distribution

Cell Type Specificity

Developmental Regulation

Disease Implications

Alzheimer's Disease

Neurodevelopmental Disorders

Stroke and Cerebrovascular Disease

Atherosclerosis

Molecular Mechanisms

Reelin Signaling Cascade

Interaction Network

Therapeutic Targeting

Current Strategies

Emerging Approaches

Animal Models

Research Directions

Background

See Also

External Links

References